Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Canadian approval for Tiazac XC

Aug. 19, 2004

Dual angiotensin/endothelin antagonists prepared and tested at Kyowa Hakko

Aug. 19, 2004

Phytoestrogen shows vasodilating effects in vitro

Aug. 19, 2004

Sesame oil shows beneficial effects in hypertensive patients

Aug. 19, 2004

European approval for higher dosage of candesartan cilexetil

Aug. 18, 2004

Medinox and PUMC to develop NOX-100 in China and South Korea

Aug. 18, 2004

Selective neutral endopeptidase inhibitors reported by Pfizer scientists

Aug. 18, 2004

Curcuma longa shows cardioprotective effects in vivo

Aug. 18, 2004

New approach to cardiovascular diseases by targeting NFkappaB

Aug. 18, 2004

Potent PARP inhibitor improves cardiac and endothelial dysfunction

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...